BUFDX
Price
$32.31
Change
-$0.94 (-2.83%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

BUFDX vs VFINX

Header iconBUFDX vs VFINX Comparison
Open Charts BUFDX vs VFINXBanner chart's image
Buffalo Growth & Income
Price$32.31
Change-$0.94 (-2.83%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
BUFDX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BUFDX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUFDX is a Buy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. BUFDX (170M). BUFDX pays higher dividends than VFINX: BUFDX (1.35) vs VFINX (1.24). BUFDX was incepted earlier than VFINX: BUFDX (12 years) vs VFINX (48 years). BUFDX (2.00) and VFINX (2.00) have comparable annual turnover. VFINX has a lower initial minimum investment than BUFDX: VFINX (0) vs BUFDX (2500). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. BUFDX (24.77). VFINX return over 5 years is better than : 88.65 vs. BUFDX (83.66).
BUFDXVFINXBUFDX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years48 years-
Gain YTD23.05427.27585%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets170M1.37T0%
Annual Yield % from dividends1.351.24109%
Returns for 1 year24.7727.6390%
Returns for 3 years34.6630.99112%
Returns for 5 years83.6688.6594%
Returns for 10 years167.97193.6287%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc